Crestwood Advisors Group LLC lifted its stake in Colgate-Palmolive Company (NYSE:CL) by 1.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 216,475 shares of the company’s stock after purchasing an additional 2,334 shares during the quarter. Crestwood Advisors Group LLC’s holdings in Colgate-Palmolive were worth $15,704,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the company. American Beacon Advisors Inc. bought a new position in Colgate-Palmolive during the 1st quarter valued at about $102,000. Proficio Capital Partners LLC raised its position in Colgate-Palmolive by 16.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after purchasing an additional 207 shares during the period. OLD Second National Bank of Aurora purchased a new stake in Colgate-Palmolive in the 2nd quarter worth about $109,000. Harbour Capital Advisors LLC purchased a new stake in Colgate-Palmolive in the 1st quarter worth about $121,000. Finally, Hanson & Doremus Investment Management raised its position in Colgate-Palmolive by 4.5% in the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after purchasing an additional 70 shares during the period. Hedge funds and other institutional investors own 73.10% of the company’s stock.

Shares of Colgate-Palmolive Company (NYSE CL) opened at 72.44 on Wednesday. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The company has a 50 day moving average price of $71.88 and a 200 day moving average price of $73.18. The company has a market capitalization of $63.81 billion, a P/E ratio of 26.92 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The firm had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter last year, the company posted $0.70 EPS. The firm’s quarterly revenue was down .5% on a year-over-year basis. Equities analysts anticipate that Colgate-Palmolive Company will post $2.89 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date is Friday, October 20th. Colgate-Palmolive’s payout ratio is 59.48%.

Several brokerages have issued reports on CL. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a research report on Tuesday, July 4th. Jefferies Group LLC upped their target price on Colgate-Palmolive from $76.00 to $77.00 and gave the company a “hold” rating in a research note on Thursday, July 6th. Royal Bank Of Canada reiterated a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a report on Friday, June 30th. Deutsche Bank AG reiterated a “hold” rating and issued a $75.00 price target on shares of Colgate-Palmolive in a report on Monday, July 24th. Finally, Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a research note on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, thirteen have given a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $76.31.

COPYRIGHT VIOLATION WARNING: This news story was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/04/crestwood-advisors-group-llc-has-15-70-million-stake-in-colgate-palmolive-company-cl.html.

In other news, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction on Monday, July 17th. The stock was sold at an average price of $72.41, for a total value of $277,547.53. Following the completion of the sale, the insider now directly owns 53,022 shares of the company’s stock, valued at $3,839,323.02. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP John J. Huston sold 14,000 shares of Colgate-Palmolive stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $71.36, for a total value of $999,040.00. Following the completion of the sale, the senior vice president now directly owns 88,598 shares of the company’s stock, valued at $6,322,353.28. The disclosure for this sale can be found here. In the last three months, insiders sold 217,969 shares of company stock worth $15,693,933. 1.02% of the stock is owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.